At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 42 enrolled
Drug / intervention
Cholestyramine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Single Blind Placebo Controlled Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study in Generally Healthy Subjects
Louisville Metabolic and Atherosclerosis Research Center·interventional·Posted Feb 4, 2010·Updated Jul 12, 2011
In Brief
A Phase 4 clinical trial evaluating Cholestyramine and Tang for Healthy. Completed, enrolled 42 participants across 1 site.
Detailed Summary
The purpose of the research study is (1) to rate the taste, texture, appearance, and mixability of 2 different doses of orange flavored cholestyramine compared to orange flavored Tang, (2) rank the importance of the taste, texture, appearance, and mixability when rating cholestyramine and Tang to determine the accuracy and usefulness of a taste test questionnaire.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsProvident Clinical Research, Daiichi Sankyo
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2010
Primary CompletionFeb 2010
First PostedFeb 2010
Study CompletionApr 2010
TodayJul 2026
First PostedFeb 4, 2010
Enrollment StartJan 1, 2010
Primary CompletionFeb 1, 2010
Study CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.4 years ago
Interventions
Cholestyraminedrug
Cholestyramine 4 grams one time dose
Cholestyraminedrug
Cholestyramine 12 grams one dose, one day
Tangdrug
Tang one dose one day